Dexcom Reports Fourth Quarter and Fiscal Year 2019 Financial Results

Go back to Dexcom Reports Fourth Quarter and Fiscal Year 2019 Financial Results

DexCom (DXCM) Tops Q4 EPS by 41c, Revenues Beat; Offers FY20 Revenue Guidance

February 13, 2020 4:02 PM EST

DexCom (NASDAQ: DXCM) reported Q4 EPS of $1.15, $0.41 better than the analyst estimate of $0.74. Revenue for the quarter came in at $462.8 million versus the consensus estimate of $442.38 million.

Fourth Quarter 2019 Highlights:

Revenue grew 37% versus the same quarter of the prior year to $462.8... More